BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8665636)

  • 1. Cardiac implications of amlodipine-dantrolene combinations.
    Freysz M; Timour Q; Bernaud C; Bertrix L; Faucon G
    Can J Anaesth; 1996 Jan; 43(1):50-5. PubMed ID: 8665636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
    Timour Q; Aupetit JF; Freysz M; Frassati D; Faucon G
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1308-14. PubMed ID: 9047040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.
    Timour Q; Bui-Xuan B; Faucon G; Aupetit JF
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):447-54. PubMed ID: 8924058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine.
    Saltzman LS; Kates RA; Corke BC; Norfleet EA; Heath KR
    Anesth Analg; 1984 May; 63(5):473-8. PubMed ID: 6711841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
    Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
    Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
    Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G
    Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine, a long-acting calcium antagonist drug reduces ischemia-induced ventricular conduction delay in pig hearts.
    Rämö MP; Plowden JS; Gabel M; Millard RW; Lathrop DA
    Am J Cardiol; 1989 Nov; 64(17):78I-83I. PubMed ID: 2530889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart.
    Pelleg A; Roth A; Shargordsky B; Belhassen B; Chagnac A; Laniado S
    Methods Find Exp Clin Pharmacol; 1985 May; 7(5):239-43. PubMed ID: 4033300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dantrolene and verapamil on atrioventricular conduction and cardiovascular performance in dogs.
    Lynch C; Durbin CG; Fisher NA; Veselis RA; Althaus JS
    Anesth Analg; 1986 Mar; 65(3):252-8. PubMed ID: 3954091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulnerability to ventricular fibrillation related to ischaemia: comparison of the acute effects of beta-blockers and calcium antagonists.
    Aupetit JF; Timour Q; Freysz M; Loufoua-Moundanga J; Omar S; Chevrel G; Faucon G
    Arch Int Pharmacodyn Ther; 1994; 327(1):25-39. PubMed ID: 7944825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
    Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
    Cheng CP; Noda T; Nordlander M; Ohno M; Little WC
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1232-41. PubMed ID: 8138936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Kioueh I; Omar S; Chevrel G; Faucon G
    Fundam Clin Pharmacol; 1992; 6(4-5):159-67. PubMed ID: 1427561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog.
    Ishizaka T; Takahara A; Iwasaki H; Mitsumori Y; Kise H; Nakamura Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):135-43. PubMed ID: 19906049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.